VN Research & Consulting
 Like us on facebook  Follow us on twitter  Follow us on LinkedIn  IndiaNotes on Google Plus  IndiaNotes on Pinterest  IndiaNotes on Stumbleupon  Subscribe to our feeds


Stocks  A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Go
Feedback
You are here : IndiaNotes >> Research & Analysis >> Companies >> Caplin Point Laboratories Ltd. >> Research

Caplin Point Laboratories Q4FY17: Fundamental Analysis - Firstcall India Equity

Firstcall India Equity | 17 May, 2017  | Follow Author | Add to my Favourites 
  • Rate this article
    (Average Rating 0.0 Based on 0 ratings)



SYNOPSIS

  • Caplin Point Laboratories is one of the fastest growing mid-cap pharmaceutical companies in India.
  • Consolidated revenue for the quarter rose by 47.14% to Rs. 1205.24 mn from Rs. 819.10 mn, when compared with the prior year period.
  • During Q4 FY17, consolidated EBIDTA is Rs. 476.37 mn as against Rs. 221.01 mn in Q4 FY16, an increased by 115.54%.
  • During Q4 FY17, consolidated PBT increased by 118.89% to Rs. 426.11 mn from Rs. 194.67 mn in Q4FY16.
  • During Q4 FY17, consolidated net profit jumps to Rs.334.09 mn from Rs. 155.82 mn in Q4 FY16, an increase of 114.40%.
  • EPS of the company stood at Rs. 4.42 a share during the quarter, as against Rs. 10.31 per share over previous year period.
  • The company has recommended a Dividend of 75% (i.e) Rs. 1.50 paise per equity share at the face value of Rs.2 each for the financial year ended March 31, 2017.
  • During the year ended 31St March, 2017, consolidated Revenue and Net Profit after Tax stood at Rs. 4050.97 mn and Rs. 961.59 mn, respectively.
  • Net Sales and PAT of the company are expected to grow at a CAGR of 22% and 34% over 2016 to 2019E respectively.


OUTLOOK AND CONCLUSION

  • At the current market price of Rs. 484.80, the stock P/E ratio is at 32.65 x FY18E and 27.90 x FY19E respectively.
  • Earning per share (EPS) of the company for the earnings for FY18E and FY19E is seen at Rs. 14.85 and Rs. 17.38 respectively.
  • Net Sales and PAT of the company are expected to grow at a CAGR of 22% and 34% over 2016 to 2019E respectively
  • On the basis of EV/EBITDA, the stock trades at 22.42 x for FY18E and 19.10 x for FY19E.
  • Price to Book Value of the stock is expected to be at 13.28 x and 11.17 x for FY18E and FY19E respectively.
  • Hence, we say that, we are Overweight in this particular scrip for Medium to Long term investment.

 


  Read full report Click here to read the full report

 
BSE
551.95 +7.90
(1.45%)
NSE
552.35 +0.00
(0.00%)
Read More
About Firstcall India Equity

Firstcall India Equity of Firstcall India Equity Advisors Pvt. Limited (FIEA), is a leading financial services provider in India and a SEBI Registered Category-I Merchant Banker. FIEA is a culmination of a credible Equity Research Capabilities, Long Standing Relationship with leading FIIs, DFIs, MFs, Overseas Pension Funds etc. The company’s research caters to the needs of the largest news wire and media houses of the world namely Reuters, Thomson, Capital IQ, Themarkets.com, Emerging Markets Euro money Publications-UK. The Company is among the major players in the Debt and Equity markets.


For more information please write in to [email protected]

 

Disclaimer: The author has taken due care and caution to compile and analyse the data. The opinions expressed above are only the views of the author, and not a recommendation to buy or sell. Neither the author nor IndiaNotes.com accept any liability whatsoever arising from the use of any of the above contents.




Technical Calls

What are technical calls?

Other Articles


Have a question?